The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCom.int.bk.regs Regulatory News (CBKD)

Share Price Information for Com.int.bk.regs (CBKD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.52
Bid: 1.518
Ask: 1.524
Change: 0.008 (0.53%)
Spread: 0.006 (0.395%)
Open: 1.48
High: 1.528
Low: 1.48
Prev. Close: 1.512
CBKD Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EGM Resolutions - March 25th, 2024

26 Mar 2024 07:00

RNS Number : 1980I
Commercial Intnl Bank (Egypt) SAE
26 March 2024
 

 

1/2

 

Summary of Resolutions

of Extraordinary General Assembly

March 25th, 2024

 

Issuance of Financial Instruments

 

In light of Article (19) of the Bank's statute, and the Board of Directors' approval dated February 11, 2024, the Extraordinary General Assembly approved the following:

 

First: To delegate the Board of Directors to issue financial instruments (senior or subordinated bonds or subordinated Debt or subordinated deposits or hybrid financial instruments) to finance various business activities up to a maximum of one billion US dollars or their equivalent in local or other foreign currencies, in addition to the remaining balance of the approval issued during the Extraordinary General Assembly, which was held on 20 March 2023. All subordinated instruments can be included at the Bank Capital and/or Tier II recognition. The financial instruments could be tradable, and also could be subordinated (the bondholder or lender has to waive his repayment priority right) according to the discretion of the Board of Directors in accordance to the CBE regulations.

 

Second: To delegate the Board of Directors in determining the date and all terms of issuance and in amending any term as requested by the governing authorities or as viewed necessary by the Board in light of the market perceived conditions and in compliance with the prevailing laws.

 

Third: To delegate the Board of Directors in fulfilling all issuance procedures during the three years in accordance with the Companies Law No.159 for the year 1981 and Capital Market Law No. 95 for the year 1992 and their executive regulations.

 

Following is the issuance structure:

 

1) Value of the issuance:

A maximum of USD 1 Billion or its equivalent in Local/ Foreign Currency to be issued in one or more tranches through a public offering or a private placement either through local or international markets, in accordance with the decision of the Board of Directors.

 

2) Purpose of Issuance:

To strengthen the bank's capital base, to accommodate any future expansion and /or investments and/ or investments in Risk-Weighted Assets and/ or to finance the commercial banking activities, in accordance with the decision of the Board of Directors.

 

 

2/2

 

 

3) Face Value:

The Board of Directors will determine the face value per bond for each issuance locally and internationally.

 

4) Issuance fees and commission:

The Board of Directors will set the fees and commissions for the issuance of the financial instruments in Egyptian Pounds or foreign currency in accordance with the prevailing market conditions.

 

5) Rate of Return:

A fixed or floating rate of return will be determined by the Board of Directors for each issuance.

 

6) Coupon Tenor or Interest payment dates:

To be determined by the Board of Directors for each issuance

 

7) Minimum Subscription Amount:

 To be determined by the Board of Directors for each issuance.

 

8) Other Terms:

The General Assembly delegated the Board of Directors in fulfilling all necessary steps and procedures in relation to the issuance, dates and methods of issuance, currency for each tranche, returns, related fees and commissions, determining fees and commissions to be paid to foreign banks involved in the issuance in accordance to the international standards, determining any other terms for the issuance of the financial instruments, whether over one or more tranches and in amending any term as necessary provided that it is in compliance with the prevailing laws and delegating the CEO and Managing Director and/ or his Deputy or whomever he delegates in handling all administrative affairs and fulfilling all necessary procedures related to the issuance of the referred to financial instruments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSEMFLIELSESD
Date   Source Headline
2nd Jul 20138:18 amRNSAGM Resolutions
7th Jun 20137:00 amRNSNotice of EGM
7th Jun 20137:00 amRNSNotice of AGM
23rd May 20138:13 amRNSChanges in CIB's Board of Directors structure
16th May 20137:00 amRNS1st Quarter Results
16th May 20137:00 amRNS1st Quarter Results Earning Release
16th May 20137:00 amRNS1st Quarter Results
21st Mar 20133:40 pmRNSPrice Monitoring Extension
20th Feb 20137:00 amRNSFinal Results
20th Feb 20137:00 amRNSAGM Statement
20th Feb 20137:00 amRNSFinal Results
20th Feb 20137:00 amRNSFinal Results
14th Jan 20137:00 amRNSPress Release regarding new CBE governor
28th Dec 20123:46 pmRNSSecond Price Monitoring Extn
28th Dec 20123:40 pmRNSPrice Monitoring Extension
27th Dec 20123:45 pmRNSSecond Price Monitoring Extn
27th Dec 20123:40 pmRNSPrice Monitoring Extension
14th Nov 20127:00 amRNS3rd Quarter Results Press Release
14th Nov 20127:00 amRNS3rd Quarter Results
14th Nov 20127:00 amRNS3rd Quarter Results
15th Aug 20127:00 amRNS1st Half 2012 unconsolidated financial statements
15th Aug 20127:00 amRNS1st Half 2012 earnings release
15th Aug 20127:00 amRNS1st Half 2012 financial statements
10th May 20127:00 amRNSQ1'2012 Stand-alone Financials
10th May 20127:00 amRNSQ1'2012 Consolidated Financials
10th May 20127:00 amRNSQ1'2012 Press Release
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Standalone Financials
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Consolidated Financials
23rd Feb 20127:00 amRNSCIB's 2011 Year-end Earning Release
1st Dec 20117:00 amRNSPress Release
16th Nov 20117:00 amRNS3rd Quarter Results - Press Release
16th Nov 20117:00 amRNS3rd Quarter Results
16th Nov 20117:00 amRNS3rd Quarter Results
11th Aug 20117:00 amRNSCIB's 1st Half Earnings Release
11th Aug 20117:00 amRNSCIB's 1st Half Unconsolidated Financial Statements
11th Aug 20117:00 amRNSCIB's 1st Half Consolidated Financial Statements
12th May 20117:00 amRNSManagement Comments on 1st Quarter Results
12th May 20117:00 amRNSUnconsolidated 1st Quarter Results
12th May 20117:00 amRNS1st Quarter Results
24th Mar 20111:44 pmRNSNotice of EGM after changing the venue
23rd Mar 20117:33 amRNSNotice of EGM
24th Feb 20117:00 amRNSCIB Press Release regarding 2010 full year results
24th Feb 20117:00 amRNSCIB's 2010 Consolidated year end financial result
24th Feb 20117:00 amRNSCIB 2010 Unconsolidated Year end financial results
11th Nov 20107:00 amRNSManagement Comments on 3rd Quarter results
11th Nov 20107:00 amRNSCIB Unconsolidated 3rd Quarter Results
11th Nov 20107:00 amRNS3rd Quarter Results
11th Aug 20107:00 amRNSCIB 1H 2010 Press Release
11th Aug 20107:00 amRNSStandalone Financial Statements
11th Aug 20107:00 amRNSConsolidated Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.